Careprost medicine suppliers & exporter in Portugal. Careprost 0.03 is an eye solution that works to control the progression of Glaucoma. It comes with an active component of Bimatprost 0.03%. The manufacturing of the medicine is done for Sun Pharma Laboratories Ltd. It is effective to resolve the problem of intraocular pressure by increasing outflow of fluid from the eyes. The eye solution is also effective to help enhance eye lash growth.
Some facts about Bimatprost 0.03%
To help resolve the problem of increased pressure in the eyes, the active substance of the medicine works best in the reduction of intraocular pressure. Useful for open eye glaucoma, the medicine works either alone or in combination. Regular use can help reduce eye pressure by releasing fluid from the eyes. With full effects, it also works to promote eye lashes growth.
How to take the medicine
The dose and dosage of the eye solution is prescribed by the doctor. Wash hands before use of the eye solution. By removing lenses from eyes, one needs to use an appropriate amount of solution amount. Wipe off the extra liquid. One can put back lenses after 15min of solution use. It is for external use only.
Who should not take the medicine?
An individual who is sensitive or allergic to the active component needs to avoid use of solution. The eye drop is probably safe but requires proper medical attention before its use. It might represent significant risk factors if a person is suffering from life threatening health issues. One needs to avoid use of machinery work when on medication.
Cautions before taking the medicine
Avoid use of overdose or double dose of the eye solution. It might affect the health of an individual. One needs to seek medical attention if health effects persist. The medicine should be avoided from pregnant or breastfeeding woman.
Some side effects of the medicine
Itching, cough, redness, watery eyes, eye lash growth are some of the health effects of the solution. If these health effects persist, one needs to avoid use of eye solution.